@incollection{,
	
					
					
					C46AA9882C627736F8E813A959ACC464
				,
	author={{Jan J.Alshmani} and {Hawler Medical University}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1461721
}

@incollection{b0,
	
	
		,
	title={{Troponin: the Biomarker of choice for the detection of Cardiac Injury}}
		,
	author={{
			LBabuin
		} and {
			ASJaffe
		}}
		
	
	
		,
	journal={{CMAJ}}
		
			173
			10
			
			,
	year={2005}
		
	

}

@incollection{b1,
	
	
		,
	title={{Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart}}
		,
	author={{
			MOBoluyt
		} and {
			XLong
		} and {
			TEschenhagen
		} and {
			UMende
		} and {
			WSchmitz
		} and {
			MTCrow
		} and {
			EGLakatta
		}}
		
		
		
		
		
		
	
	
		,
	journal={{Am J. Physiol}}
		
			269
			2
			
			,
	year={1995}
		
	
	,
	note={Pt 2}

}

@incollection{b2,
	
	
		,
	title={{Cardiac troponin I in isoproterenol-induced cardiac injury in the Hanover Wistar rat: studies on low dose levels and routes of administration}}
		,
	author={{
			SBrady
		} and {
			MYork
		} and {
			CScudamore
		} and {
			TWilliams
		} and {
			WGriffiths
		} and {
			JTurton
		}}
		
		
		
		
		
	
	
		,
	journal={{ToxicolPathol}}
		
			38
			2
			
			,
	year={2010}
		
	

}

@incollection{b3,
	
	
		,
	title={{Dilated Cardiomyopathy Pathology}}
		,
	author={{
			APBurke
		}}
	
	
		,
	booktitle={{Medscape: Drugs, Diseases and Procedures}}
				,
	editor={
			APBurke
		}
		
			,
	year={2011}
		
	

}

@incollection{b4,
	
	
		,
	title={{Angiotensin II Type 1 Receptor Blockers}}
		,
	author={{
			MBurnier
		}}
	
	
		,
	journal={{Circulation}}
		
			103
			6
			
			,
	year={2001}
		
	

}

@incollection{b5,
	
	
		,
	title={{Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKC? in the heart, which are mitigated by endothelin receptor antagonist CPU0213}}
		,
	author={{
			YSCheng
		} and {
			DZDai
		} and {
			YDai
		}}
		
		
	
	
		,
	journal={{ActaPharmcol. Sin}}
		
			30
			8
			
			,
	year={2009}
		
	

}

@incollection{b6,
	
	
		,
	title={{A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats}}
		,
	author={{
			DChowdhury
		} and {
			ADTangutur
		} and {
			TNKhatua
		} and {
			PSaxena
		} and {
			SKBanerjee
		} and {
			MPBhadra
		}}
		
		
		
		
		
	
	
		,
	journal={{J. Transl Med}}
		
			11
			
			,
	year={2013. Issue1}
		
	

}

@incollection{b7,
	
	
		,
	title={{Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation}}
		,
	author={{
			AMDeschamp
		} and {
			FGSpinale
		}}
		
	
	
		,
	journal={{Cardiovasc Res}}
		
			69
			3
			
			,
	year={2006}
		
	

}

@book{b8,
	
	
		,
	title={{Biomarkers of Heart Failure in Myocarditis and Dilated Cardiomyopathy}}
		,
	author={{
			DFairweather
		} and {
			EDAbston
		} and {
			MJCoronado
		}}
		
		
		,
	editor={D. Cihakova}
		
			,
	year={2011}
			,
	publisher={InTech Europe Pub}
			16
			
			,
	address={Croatia, P}
		
	

}

@incollection{b9,
	
	
		,
	title={{New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy}}
		,
	author={{
			SamM FGopald
		}}
	
	
		,
	journal={{J. of Cardiovasc. Trans. Res}}
		
			6
			
			,
	year={2013}
		
	

}

@incollection{b10,
	
	
		,
	title={{Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endotheline-1 from fibroblasts}}
		,
	author={{
			MOGray
		} and {
			CSLong
		} and {
			JEKalinyak
		} and {
			HTLi
		} and {
			JSKarliner
		}}
		
		
		
		
	
	
		,
	journal={{Cardiovasc Res}}
		
			40
			2
			
			,
	year={1998}
		
	

}

@incollection{b11,
	
	
		,
	title={{Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system}}
		,
	author={{
			DGrimm
		} and {
			DElsner
		} and {
			HSchunkert
		} and {
			MPfeifer
		} and {
			DGriese
		} and {
			GBruckschlegel
		} and {
			FMuders
		} and {
			GA JRiegger
		} and {
			EPKromer
		}}
		
		
		
		
		
		
		
		
	
	
		,
	journal={{Cardiovasc Res}}
		
			37
			1
			
			,
	year={1998}
		
	

}

@incollection{b12,
	
	
		,
	title={{Cellular mechanisms of cardiomyopathy}}
		,
	author={{
			PAHarvey
		} and {
			LALeinwand
		}}
		
	
	
		,
	journal={{JCB}}
		
			194
			3
			
			,
	year={2011}
		
	

}

@incollection{b13,
	
	
		,
	title={{Isoproterenol induces in vivo functional and metabolic abnormalities; similar to those found in the infarcted rat heart}}
		,
	author={{
			LCHeather
		} and {
			AFCatchpole
		} and {
			DJStuckey
		} and {
			MACole
		} and {
			CACarr
		} and {
			KClarke
		}}
		
		
		
		
		
	
	
		,
	journal={{J PhysiolPharma}}
		
			60
			3
			
			,
	year={2009}
		
	

}

@incollection{b14,
	
	
		,
	title={{Correlation between serum levels of cardiac Troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin}}
		,
	author={{
			EHHerman
		} and {
			JZhang
		} and {
			SELipshultz
		} and {
			NRifai
		} and {
			DChadwick
		} and {
			KTakeda
		} and {
			ZXYu
		} and {
			VJFerrans
		}}
		
		
		
		
		
		
		
	
	
		,
	journal={{J. ClinOncol}}
		
			17
			7
			
			,
	year={1999}
		
	

}

@incollection{b15,
	
	
		,
	title={{Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension}}
		,
	author={{
			SIchihara
		} and {
			TSenbonmatsu
		} and {
			EPriceJr
		} and {
			TIchiki
		} and {
			FAGaffney
		} and {
			TInagami
		}}
		
		
		
		
		
	
	
		,
	journal={{Circulation}}
		
			104
			3
			
			,
	year={2001}
		
	

}

@incollection{b16,
	
	
		,
	title={{molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases}}
		,
	author={{
			SKim
		} and {
			HIwao
		}}
		
	
	
		,
	journal={{Pharmacol Rev}}
		
			52
			1
			
			,
	year={2000}
		
	

}

@incollection{b17,
	
	
		,
	title={{Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers}}
		,
	author={{
			HKakuta
		} and {
			KSudoh
		} and {
			M
		} and {
			YamagishiS
		}}
		
		
		
	
	
		,
	journal={{Int J Clin Pharmacol Res}}
		
			25
			1
			
			,
	year={2005}
		
	

}

@incollection{b18,
	
	
		,
	title={{Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure}}
		,
	author={{
			LLi
		} and {
			YZhang
		} and {
			YLi
		} and {
			BYu
		} and {
			YXu
		} and {
			SZhao
		} and {
			GuanZ
		}}
		
		
		
		
		
		
	
	
		,
	journal={{Transpl. Int}}
		
			21
			12
			
			,
	year={2008}
		
	

}

@incollection{b19,
	
	
		,
	title={{Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention}}
		,
	author={{
			BJMaron
		} and {
			JATowbin
		} and {
			GThiene
		} and {
			CAntzelevitch
		} and {
			DCorrado
		} and {
			DArnett
		} and {
			AJMoss
		} and {
			CESeidman
		} and {
			YoungJ B
		}}
		
		
		
		
		
		
		
		
	
	
		,
	journal={{Circulation}}
		
			113
			14
			
			,
	year={2006}
		
	

}

@incollection{b20,
	
	
		,
	title={{Cardiomyopathy Classification: Ongoing Debate in the Genomics Era}}
		,
	author={{
			CMccartan
		} and {
			RMason
		} and {
			SRJayasinghe
		} and {
			LRGriffiths
		}}
		
		
		
		ID-796926
	
	
		,
	journal={{Biochem Res Int}}
		
			2012
			,
	year={2012}
		
	

}

@incollection{b21,
	
	
		,
	title={{Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system}}
		,
	author={{
			PKMehta
		} and {
			KKGriendling
		}}
		
	
	
		,
	journal={{Am J Physiol Cell Physiol}}
		
			292
			1
			
			,
	year={2007}
		
	

}

@incollection{b22,
	
	
		,
	title={{Effect of Irbesartan and Enalapril in non-ST elevation acute coronary Syndrome: Results of the double-blind ARCHIPELAGO study}}
		,
	author={{
			GMontalescot
		} and {
			HDrexler
		} and {
			RGallo
		} and {
			TPearson
		} and {
			MThoenes
		} and {
			DLBhatt
		}}
		
		
		
		
		
	
	
		,
	journal={{Euro. Heart J}}
		
			30
			2
			
			,
	year={2009}
		
	

}

@incollection{b23,
	
	
		,
	title={{Isoproterenol and Angiotensin I-Converting Enzyme in Lung, Left Ventricle, and Plasma During Myocardial Hypertrophy and Fibrosis}}
		,
	author={{
			MPOcaranza
		} and {
			GDiaz-Araya
		} and {
			MChiong
		} and {
			DMu?oz
		} and {
			JPRiveros
		} and {
			REbensperger
		} and {
			SSabat
		} and {
			PIrarr?zaval
		} and {
			JEJalil
		} and {
			SLavandero
		}}
		
		
		
		
		
		
		
		
		
	
	
		,
	journal={{J. Cardio. Pharma}}
		
			40
			2
			
			,
	year={2002}
		
	

}

@incollection{b24,
	
	
		,
	title={{Comparison of Vasopeptidase inhibitor Omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction}}
		,
	author={{
			APalaniyappan
		} and {
			RR EUwiera
		} and {
			HIdikio
		} and {
			BIJugdutt
		}}
		
		
		
	
	
		,
	journal={{Mol Cell Biochem}}
		
			321
			1-2
			
			,
	year={2009}
		
	

}

@incollection{b25,
	
	
		,
	title={{Effects of longterm angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats}}
		,
	author={{
			CRicher
		} and {
			PFornes
		} and {
			CCazaubon
		} and {
			VDomergue
		} and {
			DNisato
		} and {
			JFGiudicelli
		}}
		
		
		
		
		
	
	
		,
	journal={{Cardiovasc Res}}
		
			41
			1
			
			,
	year={1999}
		
	

}

@incollection{b26,
	
	
		,
	title={{Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy}}
		,
	author={{
			VRoldán
		} and {
			FMarín
		} and {
			JRGimeno
		} and {
			FRuiz-Espejo
		} and {
			JGonzález
		} and {
			EFeliu
		} and {
			AGarcía-Honrubia
		} and {
			DSaura
		} and {
			GMorena
		} and {
			MValdés
		} and {
			VVicente
		}}
		
		
		
		
		
		
		
		
		
		
	
	
		,
	journal={{Am Heart J}}
		
			156
			1
			
			,
	year={2008}
		
	

}

@incollection{b27,
	
	
		,
	author={{
			AJSerra
		} and {
			MLHiguchi
		} and {
			SS MIhara
		} and {
			ELAntônio
		} and {
			MH HSantos
		} and {
			MT N MBombig
		} and {
			PJ FTucci
		}}
		
		
		
		
		
		
	
	
		,
	booktitle={{Exercise training prevents ?-adrenergic Hyperactivity-induced Myocardial Hypertrophy and Lesions}}
				
			,
	year={2008}
			10
			
		
	

}

@incollection{b28,
	
	
		,
	title={{Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy}}
		,
	author={{
			KShirai
		} and {
			KWatanabe
		} and {
			MMa
		} and {
			MIWahed
		} and {
			MInoue
		} and {
			YSaito
		} and {
			PSSuresh
		} and {
			TKashimura
		} and {
			HTachikawa
		} and {
			MKodama
		} and {
			YAizawa
		}}
		
		
		
		
		
		
		
		
		
		
	
	
		,
	journal={{Mol Cell Biochem}}
		
			269
			1-2
			
			,
	year={2005}
		
	

}

@incollection{b29,
	
	
		,
	title={{Attenuation of isoproterenol-mediated myocardial injury in rat by an inhibitor of polyamine synthesis}}
		,
	author={{
			URTipnis
		} and {
			GYHe
		} and {
			SLi
		} and {
			GCampbell
		} and {
			PJBoor
		}}
		
		
		
		
	
	
		,
	journal={{CardiovascPathol}}
		
			9
			5
			
			,
	year={2000}
		
	

}

@book{b30,
	
	
		,
	title={{Comparitive assessment of angiotensin receptor blockers in different clinical settings, Vasc Health Risk Manag}}
		,
	author={{
			PVerdecchia
		} and {
			FAngeli
		} and {
			SRepaci
		} and {
			GMazzotta
		} and {
			GGentile
		} and {
			ReboldiG
		}}
		
		
		
		
		
		
			,
	year={2009. 2009}
			
		
	

}

@incollection{b31,
	
	
		,
	title={{Cardiomyopathy: An Overview}}
		,
	author={{
			RWexler
		} and {
			TElton
		} and {
			APleister
		} and {
			DFeldman
		}}
		
		
		
	
	
		,
	journal={{Am Fam Physician}}
		
			79
			9
			
			,
	year={2009}
		
	

}

@incollection{b32,
	
	
		,
	title={{Characterization of troponin responses in isoproterenol-induced cardiac injury in hanoverwister rats}}
		,
	author={{
			MYork
		} and {
			CScudamore
		} and {
			SBrady
		} and {
			CChen
		} and {
			SWilson
		} and {
			MCurtis
		} and {
			GEvans
		} and {
			WGriffiths
		} and {
			MWhayman
		} and {
			TWilliams
		} and {
			TurtonJ
		}}
		
		
		
		
		
		
		
		
		
		
	
	
		,
	journal={{Toxi. Path}}
		
			35
			4
			
			,
	year={2007}
		
	

}